SMARCB1 and neoplasm: It has been suggested that AT/RT development may follow a “three-hit-model” which requires that the differentiation stage, cell-of-origin and the type of SMARCB1 inactivation (intragenic pathogenic variant, broad deletion and chromosome 22 loss in different combinations) should combine in such a way as to induce tumour development [305].